Ye Xin Zhang
Director/Board Member at Thousand Oaks Biologics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Shun Luo | M | - |
Thousand Oaks Biologics, Inc.
 Thousand Oaks Biologics, Inc. BiotechnologyHealth Technology Thousand Oaks Biologics, Inc. engages in the biopharmaceutical research and development in China, including process detection technology development and validation, process amplification, stability investigation, and pre-clinical to clinical phase sample cGMP standards. The company was founded on March 14, 2017 and is headquartered in Hainan, China. | 7 years |
| Zi Xin Deng | M | - |
Thousand Oaks Biologics, Inc.
Thousand Oaks Biologics, Inc. BiotechnologyHealth Technology Thousand Oaks Biologics, Inc. engages in the biopharmaceutical research and development in China, including process detection technology development and validation, process amplification, stability investigation, and pre-clinical to clinical phase sample cGMP standards. The company was founded on March 14, 2017 and is headquartered in Hainan, China. | - |
| Ai Ming Chen | M | - |
Thousand Oaks Biologics, Inc.
Thousand Oaks Biologics, Inc. BiotechnologyHealth Technology Thousand Oaks Biologics, Inc. engages in the biopharmaceutical research and development in China, including process detection technology development and validation, process amplification, stability investigation, and pre-clinical to clinical phase sample cGMP standards. The company was founded on March 14, 2017 and is headquartered in Hainan, China. | - |
| Lei Cai | M | 39 |
Thousand Oaks Biologics, Inc.
Thousand Oaks Biologics, Inc. BiotechnologyHealth Technology Thousand Oaks Biologics, Inc. engages in the biopharmaceutical research and development in China, including process detection technology development and validation, process amplification, stability investigation, and pre-clinical to clinical phase sample cGMP standards. The company was founded on March 14, 2017 and is headquartered in Hainan, China. | - |
| San Jiang Wang | M | - |
Thousand Oaks Biologics, Inc.
Thousand Oaks Biologics, Inc. BiotechnologyHealth Technology Thousand Oaks Biologics, Inc. engages in the biopharmaceutical research and development in China, including process detection technology development and validation, process amplification, stability investigation, and pre-clinical to clinical phase sample cGMP standards. The company was founded on March 14, 2017 and is headquartered in Hainan, China. | - |
| Shi Ming Jiang | M | - |
Thousand Oaks Biologics, Inc.
Thousand Oaks Biologics, Inc. BiotechnologyHealth Technology Thousand Oaks Biologics, Inc. engages in the biopharmaceutical research and development in China, including process detection technology development and validation, process amplification, stability investigation, and pre-clinical to clinical phase sample cGMP standards. The company was founded on March 14, 2017 and is headquartered in Hainan, China. | - |
| Xiao Ying Zhang | F | - |
Thousand Oaks Biologics, Inc.
Thousand Oaks Biologics, Inc. BiotechnologyHealth Technology Thousand Oaks Biologics, Inc. engages in the biopharmaceutical research and development in China, including process detection technology development and validation, process amplification, stability investigation, and pre-clinical to clinical phase sample cGMP standards. The company was founded on March 14, 2017 and is headquartered in Hainan, China. | - |
| Miao Li | M | - |
Thousand Oaks Biologics, Inc.
Thousand Oaks Biologics, Inc. BiotechnologyHealth Technology Thousand Oaks Biologics, Inc. engages in the biopharmaceutical research and development in China, including process detection technology development and validation, process amplification, stability investigation, and pre-clinical to clinical phase sample cGMP standards. The company was founded on March 14, 2017 and is headquartered in Hainan, China. | - |
| Yu Chen | M | 43 |
Thousand Oaks Biologics, Inc.
Thousand Oaks Biologics, Inc. BiotechnologyHealth Technology Thousand Oaks Biologics, Inc. engages in the biopharmaceutical research and development in China, including process detection technology development and validation, process amplification, stability investigation, and pre-clinical to clinical phase sample cGMP standards. The company was founded on March 14, 2017 and is headquartered in Hainan, China. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John H. Robison | M | 93 |
San Jose State University
| 3 years |
| Marianne Duhaterova | F | - |
San Jose State University
| 4 years |
| Dragos Georgescu | M | 45 |
San Jose State University
| 4 years |
| Wai Yip Lee | M | 46 |
San Jose State University
| 2 years |
| Heather L. Emmel | F | - |
San Jose State University
| 1 years |
| Kristen M. Webster | F | - |
San Jose State University
| 4 years |
| Alexander W. Fang | M | - |
San Jose State University
| 4 years |
| Scott Sonnenberg | M | 45 |
San Jose State University
| 4 years |
| Barry Crane | M | - |
San Jose State University
| 2 years |
| Jeff Garden | M | - |
San Jose State University
| 4 years |
| Samir Kaji | M | - |
San Jose State University
| 4 years |
| Chu Shing Ip | M | 53 |
San Jose State University
| 1 years |
| Philip Martin | M | - |
San Jose State University
| 2 years |
| Jennifer Ho | F | - |
San Jose State University
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 14 | 60.87% |
| China | 9 | 39.13% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ye Xin Zhang
- Personal Network
